Catherine J. Lee

1.7k total citations
45 papers, 570 citations indexed

About

Catherine J. Lee is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Catherine J. Lee has authored 45 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Public Health, Environmental and Occupational Health and 14 papers in Hematology. Recurrent topics in Catherine J. Lee's work include Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (9 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Catherine J. Lee is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (9 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Catherine J. Lee collaborates with scholars based in United States, Spain and Belgium. Catherine J. Lee's co-authors include Jack Ansell, David A. Fishman, Edgardo V. Ariztia, Bipin N. Savani, Radhika Gogoi, Daniel R. Couriel, Arnon Nagler, Mohamad Mohty, Myriam Labopin and Annalisa Ruggeri and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Catherine J. Lee

40 papers receiving 560 citations

Peers

Countries citing papers authored by Catherine J. Lee

Since Specialization

Citations

This map shows the geographic impact of Catherine J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine J. Lee more than expected).

Fields of papers citing papers by Catherine J. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine J. Lee. The network helps show where Catherine J. Lee may publish in the future.

Co-authorship network of co-authors of Catherine J. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine J. Lee. A scholar is included among the top collaborators of Catherine J. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine J. Lee. Catherine J. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT 2025 ·Transplantation and Cellular Therapy ·(unknown), Jennifer Collins, (unknown), Jill Randall, Christopher Su, Rahul Banerjee, (unknown), (unknown), Hermioni L. Amonoo, William A. Wood, Betty K. Hamilton, Anthony D. Sung, Catherine J. Lee	0
2	Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT 2025 ·Transplantation and Cellular Therapy ·Rahul Banerjee, Hermioni L. Amonoo, Anna Barata, Neel S. Bhatt, (unknown), Reena Jayani, (unknown), Vanessa E. Kennedy, (unknown), Angela Steineck, (unknown), Erin S. Costanzo, Rachel Cusatis, Jennifer M. Knight, Hélène Schoemans, Surbhi Sidana, William A. Wood, Anthony D. Sung, Catherine J. Lee, Betty K. Hamilton	0
3	Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy 2024 ·Haematologica ·Santiago Mercadal, Kwang Woo Ahn, (unknown), (unknown), Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana K. Malone, Hemant S. Murthy, Attaphol Pawarode, Alejandro Sica, Melhem Solh, Celalettin Üstün, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee	3
4	Decreasing chronic graft-versus-host disease rates in all populations 2024 ·Blood Advances ·Paul A. Carpenter, Theodore A. Gooley, (unknown), Catherine J. Lee, Lauri Burroughs, Rohtesh S. Mehta, Rachel B. Salit, Neel S. Bhatt, Elizabeth F. Krakow, Ann Dahlberg, Albert C. Yeh, Corinne Summers, Masumi Ueda, Effie W. Petersdorf, (unknown), Laura Connelly‐Smith, Stephanie J. Lee	6
5	Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Rahul Banerjee, Andrew J. Cowan, (unknown), (unknown), Paul A. Carpenter, Masumi Ueda, Rachel B. Salit, (unknown), Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher Su	16
6	A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT 2024 ·Blood Advances ·Zachariah DeFilipp, Haesook T. Kim, Guang‐Shing Cheng, Betty K. Hamilton, Saurabh Chhabra, Mehdi Hamadani, Karamjeet Sandhu, Lia Perez, Catherine J. Lee, (unknown), (unknown), (unknown), Kathleen Gallagher, Richard Newcomb, Areej El‐Jawahri, Yi‐Bin Chen	3
7	Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host Disease 2024 ·Contemporary Clinical Trials ·Betty K. Hamilton, Lynn Onstad, Paul A. Carpenter, Joseph A. Pidala, Najla El Jurdi, Nosha Farhadfar, Carrie L. Kitko, Catherine J. Lee, Rohtesh S. Mehta, George L. Chen, Corey Cutler, Stephanie J. Lee	0
8	Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature 2024 ·Annals of Hematology ·Santiago Mercadal, Alberto Mussetti, Catherine J. Lee, Carolina Arévalo, (unknown), Esteban Peña, Anna Sureda, Daniel R. Couriel	1
9	Efficacy and Safety of Processed Amniotic Fluid (pAF) Drops for the Treatment of Ocular Chronic Graft-Versus-Host Disease 2023 ·Blood ·Catherine J. Lee, John D. Phillips, Amy Lin, (unknown), (unknown), Lawrence J. Cook, Daniel R. Couriel	1
10	Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials 2023 ·Clinical Cancer Research ·Eduardo Rodríguez‐Arbolí, Catherine J. Lee, Teresa Caballero‐Velázquez, Carmen Martı́nez, (unknown), (unknown), (unknown), Lucía López‐Corral, (unknown), Lynn Onstad, Mitchell E. Horwitz, Stefanie Sarantopoulos, Stephanie J. Lee, Josè Antonio Pérez-Simón	3
11	Incident Cardiovascular Disease Risk among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Mia Hashibe, Mei Wei, Catherine J. Lee, Randa Tao, (unknown), Jing Wang, (unknown), Djin Tay, Jincheng Shen, Yuan‐Chin Amy Lee, (unknown)	1
12	Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature 2023 ·Annals of Hematology ·Santiago Mercadal, Carlos A. Gómez, Catherine J. Lee, Daniel R. Couriel	11
13	Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy 2023 ·Cancers ·(unknown), Catherine J. Lee	6
14	Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT 2022 ·Transplantation and Cellular Therapy ·Lori Muffly, Catherine J. Lee, (unknown), Ankur Varma, Bart L. Scott, Hye‐Sook Kwon, (unknown), (unknown), Mamatha M. Reddy, Kevin N. Heller, Judith A. Shizuru, Wendy W. Pang, Andrew Artz	2
15	Use of Telemedicine in Care of Hematologic Malignancy Patients: Challenges and Opportunities 2022 ·Current Hematologic Malignancy Reports ·Jennifer Lloyd, Catherine J. Lee	5
16	Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2017 ·Haematologica ·Catherine J. Lee, Bipin N. Savani, Mohamad Mohty, Myriam Labopin, Annalisa Ruggeri, Christoph Schmid, Frédéric Baron, Jordi Esteve, Norbert Claude Gorin, Sebastian Giebel, Fabio Ciceri, Arnon Nagler	56
17	Neurologic Manifestations of Blood Dyscrasias 2016 ·Hematology/Oncology Clinics of North America ·Daniel R. Couriel, (unknown), (unknown), Catherine J. Lee	6
18	Oral IIa Inhibitors 2010 ·Hematology/Oncology Clinics of North America ·Catherine J. Lee, (unknown), Jack Ansell	5
19	Conventional and Proteomic Technologies for the Detection of Early Stage Malignancies: Markers for Ovarian Cancer 2006 ·Critical Reviews in Clinical Laboratory Sciences ·Catherine J. Lee, Edgardo V. Ariztia, David A. Fishman	10
20	Comparative biodistribution of meta-Tetra (Hydroxyphenyl) chlorin in multiple species: Clinical implications for photodynamic therapy 1997 ·Lasers in Surgery and Medicine ·A.M. Ronn, (unknown), Catherine J. Lee, Don C. Yoo, (unknown), May Nouri, (unknown), Bettie M. Steinberg	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact